| scholarly article | Q13442814 |
| P2093 | author name string | Kenneth Rockwood | |
| Pierre Molin | |||
| P2860 | cites work | Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q24595802 |
| Frailty and the risk of cognitive impairment | Q26799300 | ||
| Harmonized diagnostic criteria for Alzheimer's disease: recommendations | Q27009157 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Three dimensions of the amyloid hypothesis: time, space and 'wingmen' | Q28082768 | ||
| Frailty in relation to the accumulation of deficits | Q28236725 | ||
| The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
| The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29614406 | ||
| Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria | Q29614408 | ||
| Mild cognitive impairment as a diagnostic entity | Q29619568 | ||
| Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers | Q29620245 | ||
| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria | Q30458193 | ||
| 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception | Q30971403 | ||
| The neuropathology of older persons with and without dementia from community versus clinic cohorts | Q33786327 | ||
| Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). | Q33935314 | ||
| Requiring an amyloid‐β1‐42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials | Q34162069 | ||
| Rates of decline in Alzheimer disease decrease with age. | Q34372593 | ||
| Dementia--a geriatric syndrome | Q45845612 | ||
| CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large-scale international multicenter study. | Q45975504 | ||
| Classification of vascular dementia in the Cardiovascular Health Study Cognition Study. | Q46052397 | ||
| Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease | Q46886267 | ||
| Association between comorbidity burden and rapid cognitive decline in individuals with mild to moderate Alzheimer's disease. | Q48100288 | ||
| Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post-mortem diagnosis | Q48277592 | ||
| Prediction of AD dementia by biomarkers following the NIA-AA and IWG diagnostic criteria in MCI patients from three European memory clinics | Q48346421 | ||
| Age, neuropathology, and dementia | Q48597534 | ||
| Auguste D and Alzheimer's disease | Q48705089 | ||
| Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort study | Q48738661 | ||
| Lack of accuracy for the proposed 'Dubois criteria' in Alzheimer's disease: a validation study from the Swedish brain power initiative. | Q51034040 | ||
| Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias. | Q51912690 | ||
| Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. | Q53243175 | ||
| Revising the definition of Alzheimer's disease: a new lexicon. | Q53313597 | ||
| Dementia in the oldest old | Q57724897 | ||
| Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease | Q70994207 | ||
| A population perspective on the IWG-2 research diagnostic criteria for Alzheimer's disease | Q87924114 | ||
| Age-related deficit accumulation and the risk of late-life dementia | Q34418955 | ||
| Emerging concepts in Alzheimer's disease | Q34447306 | ||
| Mixed dementia: emerging concepts and therapeutic implications | Q34553430 | ||
| Applying a cumulative deficit model of frailty to dementia: progress and future challenges | Q34571670 | ||
| Role of the neuropathology of Alzheimer disease in dementia in the oldest-old | Q34764490 | ||
| Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial | Q34798154 | ||
| Nontraditional risk factors combine to predict Alzheimer disease and dementia | Q35104464 | ||
| Distinct profiles of brain and cognitive changes in the very old with Alzheimer disease | Q35188332 | ||
| Outcomes of incident mild cognitive impairment in relation to case definition | Q35489520 | ||
| Cumulative impact of health deficits, social vulnerabilities, and protective factors on cognitive dynamics in late life: a multistate modeling approach | Q35687278 | ||
| Age and diagnostic performance of Alzheimer disease CSF biomarkers. | Q35758640 | ||
| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis | Q35800785 | ||
| Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis | Q35896890 | ||
| Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease | Q35948528 | ||
| Evidence for ordering of Alzheimer disease biomarkers | Q36071403 | ||
| Overview and findings from the religious orders study | Q36130996 | ||
| Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia | Q36183800 | ||
| Overview and findings from the rush Memory and Aging Project | Q36226167 | ||
| Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4) | Q36450937 | ||
| Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging | Q36600399 | ||
| An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease | Q36650399 | ||
| The Honolulu-Asia Aging Study: epidemiologic and neuropathologic research on cognitive impairment | Q36697980 | ||
| Application of the National Institute on Aging-Alzheimer's Association AD criteria to ADNI | Q37027184 | ||
| Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage | Q37237863 | ||
| Mild cognitive impairment due to Alzheimer disease in the community | Q37245465 | ||
| Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal | Q37593256 | ||
| Examination of the clinicopathologic continuum of Alzheimer disease in the autopsy cohort of the National Alzheimer Coordinating Center | Q37656915 | ||
| Making Alzheimer's and dementia research fit for populations | Q37682629 | ||
| Frailty and cognitive impairment--a review of the evidence and causal mechanisms. | Q38119835 | ||
| Cognitive aspects of frailty: mechanisms behind the link between frailty and cognitive impairment. | Q38366832 | ||
| Neuropathology of older persons without cognitive impairment from two community-based studies | Q38405842 | ||
| The case for rejecting the amyloid cascade hypothesis. | Q38501528 | ||
| Longitudinal change of biomarkers in cognitive decline | Q41719639 | ||
| New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population. | Q42981315 | ||
| Prevalence of dementia disorders in the oldest-old: an autopsy study. | Q43746409 | ||
| P433 | issue | 2 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 66-73 | |
| P577 | publication date | 2016-06-29 | |
| P1433 | published in | Canadian geriatrics journal : CGJ | Q27724402 |
| P1476 | title | The New Criteria for Alzheimer's Disease - Implications for Geriatricians | |
| P478 | volume | 19 |
| Q42251140 | The June Issue of the CGJ. | cites work | P2860 |
Search more.